RE
GH icon

RBC Europe’s Guardant Health GH Stock Holding History

RBC Europe’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20
Closed -$2.5K – 821
2021
Q3 		$2.5K Hold
20
– – ﹤0.01% 1104
2021
Q2 		$2.48K Buy
20
+10
+100% +$1.34K ﹤0.01% 1102
2021
Q1 		$1.53K Sell
10
-500
-98% -$75.6K ﹤0.01% 1100
2020
Q4 		$65.7K Buy
510
+250
+96% +$28.8K ﹤0.01% 463
2020
Q3 		$29.1K Hold
260
– – ﹤0.01% 570
2020
Q2 		$21.1K Hold
260
– – ﹤0.01% 620
2020
Q1 		$18.1K Buy
260
+10
+4% +$767 ﹤0.01% 578
2019
Q4 		$19.5K Hold
250
– – ﹤0.01% 656
2019
Q3 		$16K Buy
+250
New +$22K ﹤0.01% 681

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RBC Europe's GH Position: Q4 2021 in Review

RBC Europe sold out of Guardant Health (GH) in Q4 2021, closing a stake of 20 shares — an estimated $2.5K sold.

RBC Europe first reported a position in GH in Q3 2019 and held it in 9 quarters. The position peaked at $65.7K in Q4 2020. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

  • RBC Europe reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 20 Guardant Health shares in Q4 2021, an estimated $2.5K.
  • RBC Europe first reported a position in Guardant Health in Q3 2019 and held it in 9 quarters.
  • RBC Europe's Guardant Health position peaked at $65.7K in Q4 2020.
  • 396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.